This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast To 2022

NEW YORK, April 11, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022

EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022


Dermatophytic onychomycosis (DO) is an infection of the nail fold or nail plate with dermatophytes, a type of fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton flocossom (Sterry et al., 2006). DO begins as a white/yellow spot under the tip of the nail. As the infection spreads deeper, it causes further discoloration and thickening of the nail, resulting in nail disfigurement and pain/discomfort.

The high worldwide prevalence of DO is primarily due to changes in factors relating to lifestyle, customs, and culture. The incidence and prevalence of DO in the EU was stable over a period of 30 years between the 1960s and 1990s due to a decline in industries such as coal mining, representing decreased use of industrial baths, while simultaneously there has been an increase in prevalence resulting from the use of communal recreational facilities, which led to a constant incidence of DO (Roberts, 1992; Seebacher et al., 2008). In Japan, the traditional Japanese practice of walking barefoot in the house, which facilitates the spread of the infection to family members, is the primary reason for the especially high prevalence and intensity of toenail fungal disease in Japan (Nishimoto, 2006; Watanabe et al., 2010).


- The Dermatophytic Onychomycosis (DO) EpiCast Report provides an overview of the risk factors and global trends of DO in the seven major markets (US, France, Germany, Italy, Spain, UK, and Japan). - It also includes a 10-year epidemiology forecast of the prevalent cases of DO, segmented by sex, and age (15–29 years, 30–49 years, 50–69 years, and >70 years) in these markets.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global DO market.- Quantify patient populations in the global DO market to improve product design, pricing, and launch plans.- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DO therapeutics in each of the markets covered.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.16 1.60%
FB $117.63 -0.79%
GOOG $694.98 -0.46%
TSLA $233.46 -3.40%
YHOO $36.16 -1.00%


Chart of I:DJI
DOW 17,753.92 -137.24 -0.77%
S&P 500 2,066.37 -15.06 -0.72%
NASDAQ 4,778.47 -39.1240 -0.81%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs